ArticleBriefings in bioinformatics2026
HighFold4: extending AlphaFold3 to accurate cyclic peptide conformation prediction via custom chemical connectivity.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
While AlphaFold3 has revolutionized protein structure prediction and supports noncanonical amino acids, its architecture always fails to reliably generate the closed-ring topologies characteristic of cyclic peptides. Existing adaptations, such as imposing distance constraints via an offset matrix, enforce ring geometry but cannot specify the chemical identity of the cyclization bond, leading to a restrictive bias toward amide- or disulfide-linked macrocycles. Here, we present HighFold4, a framework that adapts AlphaFold3 to explicitly incorporate user-defined chemical connectivity between residues, thereby enabling both topological closure and bond-specific cyclization. Without retraining the base model, HighFold4 achieves accurate, chemistry-aware prediction of diverse cyclic peptide conformations, as validated on 179 structures. This work established a new paradigm for the conformation construction of macrocyclic peptides with tailored ring geometry and linkage chemistry, significantly expanding the utility of deep learning in peptide-based drug discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.